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Abstract
Background: Cigarette smoking is believed to cause oxidative stress by several mechanisms,
including direct damage by radical species and the inflammatory response induced by smoking, and
would therefore be expected to cause increased lipid peroxidation. The aim was to carry out the
first study of the relationship of smoking in humans to the level of n-3 lipid peroxidation indexed
by the level of ethane in exhaled breath.
Methods: Samples of alveolar air were obtained from 11 smokers and 18 non-smokers. The air
samples were analyzed for ethane using mass spectrometry.
Results: The two groups of subjects were matched with respect to age and gender. The mean
cumulative smoking status of the smokers was 11.8 (standard error 2.5) pack-years. The mean level
of ethane in the alveolar breath of the group of smokers (2.53 (0.55) ppb) was not significantly
different from that of the group of non-smokers (2.59 (0.29) ppb; p = 0.92). With all 29 subjects
included, the Spearman rank correlation coefficient between ethane levels and cumulative smoking
status was -0.11 (p = 0.58), while an analysis including only the smokers yielded a corresponding
correlation coefficient of 0.11 (p = 0.75).
Conclusion: Our results show no evidence that cigarette smoking is related to increased n-3 lipid
peroxidation as measured by expired ethane.
Background
The smoking of cigarettes by humans is believed to cause
oxidative stress by several mechanisms, including direct
damage by radical species and the inflammatory response
induced by smoking [1,2]: peroxyl radicals and reactive
nitrogen species cause direct damage, stimulating lipid
peroxidation, oxidizing and nitrating proteins, lipids and
DNA bases; aldehydes can deplete GSH (reduced glutath-
ione) and modify protein -SH and -NH2 groups; cigarette
smoke tar phase hydroquinone/quinine complexes dif-
fuse across cell membranes and give rise to semiquinones,
superoxide radicals (O2·-) and hydrogen peroxide
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which in turn leads to increased oxidative stress. There-
fore, cigarette smoking would be expected to be associated
with increased lipid peroxidation. It is possible to meas-
ure lipid peroxidation in humans using a non-invasive
sensitive measure of free radical damage by analyzing
directly the early products of oxidation in exhalant vola-
tile hydrocarbons [3]. In particular, the volatile hydrocar-
bon ethane is produced as a terminal catabolite of
polyunsaturated fatty acid oxidation and is excreted in the
breath. Hence, the level of expired ethane would be
expected to be higher in smokers than in age- and gender-
matched non-smokers.
However, in a recent study by our group into lipid perox-
idation in schizophrenia, while an increased level of
expired ethane was found in patients with schizophrenia
compared with normal controls, an incidental, and unex-
pected, finding was that there appeared to be no differ-
ence in expired ethane between smokers and non-
smokers in the control group [4]. If replicated in a more
systematic study of normal controls, this would be an
important finding in studies of lipid peroxidation in those
psychiatric disorders, such as schizophrenia, in which
smoking appears to be particularly common.
We report the first study of the relationship of smoking in
humans to the level of n-3 lipid peroxidation indexed by
the level of ethane in exhaled breath.
Methods
Subjects
29 normal control subjects were studied. There was no
history of neurological or psychiatric disorder, nor of pul-
monary disorders such as chronic obstructive pulmonary
disease, in any of the subjects. 11 of the subjects were
long-term smokers, while the remaining 18 subjects were
non-smokers.
The study was carried out according to the Declaration of
Helsinki. The subjects were given both verbal and written
details of the study and gave written informed consent.
The study was approved by the local research ethics com-
mittee.
Exhalant analysis
Each subject was asked to exhale through a disposable
sterile mouthpiece into a syringe (Markes International
Ltd., UK) in one long breath, until they were no longer
able to exhale any further. This enabled alveolar (end
expired) air to be collected from the lungs. The air sample
was then injected into an automated thermal desorption
tube packed with carbotrap 300 (Perkin-Elmer, UK) via a
sodium sulphate drying cartridge (International Sorbent
Technology, UK). The air samples were analyzed using a
Perkin-Elmer autosystem XL equipped with a turbo mass
spectrometer. The automated thermal desorption tubes
were desorbed onto the cold trap at 320°C, with the cold
trap temperature being held at 5°C. The trap was then rap-
idly heated to 350°C and the liberated volatiles injected
onto a 30 m × 0.32 mm PLOT GQ column (Perkin-Elmer,
UK) with helium gas at 2 ml min-1. The oven was set at
45°C for 10 min and ramped at 14°C min-1 to 200°C at
which temperature it was held for 120 s. Ethane (C2H6)
was eluted at 2.6 min and identified and quantified by
mass spectrometry at an m/z value of 30 by comparison
with a standard curve (0–60 pmol) constructed from a
C1–C6 alkane standard mix (Supelco, UK).
For the ethane assay, variability and stability data were
obtained using a group of 10 controls tested five days in a
row with five tubes per test day. Inter-assay variability (as
(standard deviation)/mean × 100%) was 17% and intra-
assay variability was 10%. The method used was thermal
desorption which is a very good way of collecting and
immobilizing gases. The gas levels can reduce on the tube
owing to chemical instability and simple desorption and
diffusion. For the former ethane is a chemically stable
molecule but desorption can occur. This was tested by
introducing standards in air onto the tubes and testing at
various times thereafter. It was found that after one week
tubes retained 97% ethane, while retention was 95% after
two weeks, and 90% after one month. Therefore the level
diminishes over time, but slowly. Our samples were ana-
lyzed within one week of collection.
Statistical analyses
Statistical analyses were carried out using the SPSS version
12 statistics program (SPSS Inc., Chicago).
Results
Subjects
There was no significant difference between the smokers
and the group of non-smokers in respect of mean age
(smokers first: 36.6 (standard error 2.4) years; 34.9 (2.6)
years) or gender (five men and six women; eight men and
10 women). The cumulative smoking status for each of
the two groups was as follows: smokers mean (S.E.) 11.8
(2.5) pack-years; non-smokers mean (S.E.) 0 (0) pack-
years (p < 0.00001).
Expired ethane
As illustrated in Figure 1, the mean level of ethane in the
alveolar breath of the group of smokers (2.53 (S.E. 0.55)
ppb) was not significantly different from that of the group
of non-smokers (2.59 (S.E. 0.29) ppb; t = 0.105, df = 27, p
= 0.92).
Further post-hoc analyses were carried out to determine
whether there was a correlation between ethane levels andPage 2 of 4
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With all 29 subjects included, the Spearman rank correla-
tion coefficient was -0.11 (p = 0.58), while an analysis
including only the smokers yielded a Spearman rank cor-
relation coefficient of 0.11 (p = 0.75). Thus there was no
significant correlation between ethane levels and cumula-
tive smoking status.
Discussion
This first systematic study of expired ethane in relation to
smoking in humans has shown no significant difference
between smokers and age- and gender-matched non-
smokers, and no significant correlation between expired
ethane and cumulative smoking status. These surprising
results confirm the earlier indications from our recent
study of patients with schizophrenia [4]. There are two
sets of findings that may be germane to an understanding
of these results.
First, a recent detailed review of oxidative damage to lipids
caused by smoking, examining studies which have
assayed lipid peroxidation by the thiobarbituric acid (and
therefore mainly malondialdehyde) assay, reported
highly inconsistent results [5]. It has been generally sup-
posed that such inconsistency might be purely a function
of difficulties with this assay, with malondialdehyde
being regarded as a relative rather than an absolute marker
of lipid peroxidation [1,5].
Second, given that increased lipid peroxidation (and other
radical-mediated damage) might be expected to cause
some depletion of vitamin E and other antioxidants, it
would seem reasonable to expect smoking to be associ-
ated with a reduction in such antioxidants. However, it is
noteworthy that, while in vitro exposure of plasma to cig-
arette smoke does indeed deplete vitamin E and other
antioxidants [2], in vivo studies have yielded inconsistent
findings, with some studies showing reduced levels of
alpha- and gamma-tocopherol in smokers compared with
non-smokers [6,7], while at least four others have shown
no significant difference between smokers and non-smok-
ers [8-11].
These two sets of findings may be consistent with our
results. Although it is difficult to explain, it may be that
cigarette smoking is not necessarily associated with
increased lipid peroxidation. Further research is clearly
required in order, first, to confirm that expired ethane
may not be raised in smokers compared with non-smok-
ers, and second, to understand the mechanisms by which
cigarette smoking might not lead to increased lipid perox-
idation.
Conclusion
Our results show no evidence that cigarette smoking is
related to increased n-3 lipid peroxidation as measured by
expired ethane.
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